Source: Annual Congress 2007 - New developments in thoracic imaging modalities and illustrated thorax pathologies



Rating:

Share or cite this content

Citations should be made in the following way:
K. Harris, G. Smaldone (Stony Brook, NY, United States Of America). Bench performance and lung deposition of the I-neb adaptive aerosol delivery system. Eur Respir J 2007; 30: Suppl. 51, 720

Member's Comments

No comment yet.

Related content which might interest you: Lung deposition of 99mTc-DTPA delivered with an adaptive aerosol delivery system Source: Eur Respir J 2007; 30: Suppl. 51, 545s Year: 2007 Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008 In vitro performance of the prodose AAD® handheld - a new portable aerosol delivery system Source: Eur Respir J 2004; 24: Suppl. 48, 581s Year: 2004 Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology Source: Annual Congress 2009 - Respiratory disorders of the newborn Year: 2009 Retrospective review of patient logging system data from an adaptive aerosol delivery system used for the delivery of iloprost inhalation solution Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Reduction of treatment time for nebulized treatments using a new adaptive aerosol delivery mode Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Comparison of aerosol delivery of AccuMist and AeroEclipse II using a breath simulator Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1 Year: 2020 Aerosol particle size output from a new nebuliser system, measured by cascade impaction Source: Eur Respir J 2005; 26: Suppl. 49, 125s Year: 2005 A new tool for monitoring patient adherence with aerosol therapy using an eflow nebulizer system Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 Lung deposition of an aerosol produced by a new inhalation device for ventilated patients Source: Eur Respir J 2005; 26: Suppl. 49, 88s Year: 2005 Effects of the Acapella® device in radioaerosol regional pulmonary deposition Source: Annual Congress 2007 - Critical care and airways clearance Year: 2007 Use of a telemedicine application to examine patient logging system data from a 3-month use of an adaptive aerosol delivery system by patients with COPD Source: Annual Congress 2008 - Integrated care and long-term strategies Year: 2008 The mesh nebuliser: a recent technical innovation for aerosol delivery Source: ISSN=ISSN 1810-6838, ISBN=, page=252 Year: 2006 Improving surfactant therapy: Development of a neonatal upper airway model for in vitro aerosol deposition testing Source: Annual Congress 2013 –Neonatal and paediatric intensive care Year: 2013 Comparison of aerosol delivery from two inhaler technique-guidance devices. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Impact of different ventilator parameters on in-vitro aerosol performance of a novel nebulizer for ventilated patients Source: Annual Congress 2009 - Airway management, mechanical ventilation and muscle weakness Year: 2009 Reusable soft mist inhaler: maintaining aerosol performance Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser Source: Eur Respir J 2007; 30: Suppl. 51, 345s Year: 2007 Precise dosing of five drugs commonly used by patients with cystic fibrosis using an adaptive aerosol delivery system Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008